ProShare Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

ProShare Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,681	Closed	-$159K	–	2355
2021 Q3	$159K	Sell	10,681 -2,546	-19%	-$37.9K	﹤0.01%	1837
2021 Q2	$264K	Buy	13,227 +1,730	+15%	+$34.5K	﹤0.01%	1974
2021 Q1	$265K	Buy	11,497 +663	+6%	+$15.3K	﹤0.01%	1870
2020 Q4	$268K	Buy	10,834 +2,341	+28%	+$57.9K	﹤0.01%	1682
2020 Q3	$352K	Sell	8,493 -708	-8%	-$29.3K	﹤0.01%	1092
2020 Q2	$441K	Buy	9,201 +2,767	+43%	+$133K	﹤0.01%	1013
2020 Q1	$405K	Sell	6,434 -4,657	-42%	-$293K	﹤0.01%	783
2019 Q4	$1.37M	Sell	11,091 -1,217	-10%	-$151K	0.01%	707
2019 Q3	$817K	Sell	12,308 -116	-0.9%	-$7.7K	﹤0.01%	823
2019 Q2	$989K	Sell	12,424 -907	-7%	-$72.2K	0.01%	761
2019 Q1	$1.49M	Buy	13,331 +326	+3%	+$36.5K	0.01%	660
2018 Q4	$1.31M	Sell	13,005 -2,502	-16%	-$252K	0.01%	655
2018 Q3	$1.96M	Sell	15,507 -309	-2%	-$39K	0.01%	611
2018 Q2	$1.33M	Buy	15,816 +3,724	+31%	+$312K	0.01%	736
2018 Q1	$744K	Sell	12,092 -1,912	-14%	-$118K	﹤0.01%	942
2017 Q4	$818K	Sell	14,004 -558	-4%	-$32.6K	0.01%	918
2017 Q3	$845K	Buy	14,562 +1,353	+10%	+$78.5K	0.01%	773
2017 Q2	$1.6M	Sell	13,209 -407	-3%	-$49.3K	0.02%	611
2017 Q1	$1.54M	Sell	13,616 -3,026	-18%	-$342K	0.02%	625
2016 Q4	$1.81M	Buy	16,642 +473	+3%	+$51.4K	0.02%	578
2016 Q3	$2.66M	Sell	16,169 -2,721	-14%	-$448K	0.04%	413
2016 Q2	$2.7M	Buy	18,890 +451	+2%	+$64.3K	0.03%	398
2016 Q1	$2.37M	Sell	18,439 -1,774	-9%	-$228K	0.03%	401
2015 Q4	$3.02M	Buy	20,213 +1,130	+6%	+$169K	0.04%	393
2015 Q3	$3.17M	Sell	19,083 -900	-5%	-$149K	0.04%	353
2015 Q2	$4.82M	Buy	19,983 +1,252	+7%	+$302K	0.07%	274
2015 Q1	$5.28M	Buy	18,731 +4,022	+27%	+$1.13M	0.06%	303
2014 Q4	$2.3M	Buy	+14,709	New	+$2.3M	0.03%	529
2014 Q2	–	Sell	-7,270	Closed	-$2.4M	–	2650
2014 Q1	$2.4M	Buy	+7,270	New	+$2.4M	0.03%	642
2013 Q4	–	Sell	-4,528	Closed	-$313K	–	1957
2013 Q3	$313K	Buy	+4,528	New	+$313K	0.01%	1873